fenvalerate has been researched along with bromodeoxyuridine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bortner, C; Castro, L; Dixon, D; Gao, X; Hermon, T; Moore, AB; Sifre, M; Yu, L | 1 |
Castro, L; Dixon, D; Gao, X; Moore, AB; Tucker, CJ; Xiao, H; Yu, L | 1 |
2 other study(ies) available for fenvalerate and bromodeoxyuridine
Article | Year |
---|---|
An endocrine-disrupting chemical, fenvalerate, induces cell cycle progression and collagen type I expression in human uterine leiomyoma and myometrial cells.
Topics: Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Proliferation; Collagen Type I; Endocrine Disruptors; Female; Gene Expression Regulation; Humans; Leiomyoma; Myometrium; Nitriles; Pyrethrins; Receptors, Estrogen; RNA, Messenger; Uterine Neoplasms | 2010 |
An essential role of p27 downregulation in fenvalerate-induced cell growth in human uterine leiomyoma and smooth muscle cells.
Topics: Adenoviridae; Anticonvulsants; Antimetabolites; Blotting, Western; Bromodeoxyuridine; Cell Count; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Down-Regulation; Female; Fluorescent Antibody Technique; Genetic Vectors; Humans; Leiomyoma; Microscopy, Confocal; Myocytes, Smooth Muscle; Nitriles; Pyrethrins; Real-Time Polymerase Chain Reaction; RNA, Small Interfering; Uterine Neoplasms | 2012 |